Pharmaceutical products

Tender description

The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: — Etanercept, — Infliximab, — Methotrexate. The Goods have been split into five (5) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice. This Lot is for the supply of Etanercept 10 mg, 25 mg, 50 mg presentations to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. This Lot includes the provision of Goods only and Goods with manufacturer funded homecare. Each product line will be treated as an individual Lot and will be awarded on a line by line basis. It is envisaged that each Lot will be awarded as an unranked multi supplier Framework to a maximum of three (3) Framework Participants. This Lot is for the supply Infliximab 100 mg powder for concentrate for solution for infusion to NHS Scotland. This Lot will be treated as unranked multi supplier Framework and it is envisaged it will be awarded to a maximum of five (5) Framework Participants. This Lot is for the supply of Methotrexate (50 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority intends awarding a multi-supplier unranked Framework Agreement for the Lot and it is envisaged a maximum of three (3) Framework Participants will be awarded. Full details can be found within the ITT. This Lot is for the supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority intends awarding a multi-supplier unranked Framework Agreement for the Lot and it is envisaged a maximum of three (3) Framework Participants will be awarded. Full details can be found within the ITT. This Lot is for the supply of Methotrexate (25 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority intends awarding a multi-supplier unranked Framework Agreement for the Lot and it is envisaged a maximum of three (3) Framework Participants will be awarded. Full details can be found within the ITT.